Skip to main content
Caplight Logo









Silvia Bio

Silvia Bio

Private
SheffieldHealthcare & Life Scienceshttps://silviabio.com

Last Round

Seed

Oct 15, 2026

Total Funding Raised

$3.98M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Silvia Bio is a biotechnology company that provides a platform to accelerate biomanufacturing by identifying cellular bottlenecks and delivering precision media solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biomanufacturingbioprocess optimizationcell culture mediabiologics manufacturingcell profilingmedia additivesbioprocessingbiotech servicesbioreactor yieldcell line developmentbioprocess engineeringbiopharmaupstream processingbiotech consultingcell factory engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Silvia Bio Comparables

Compare Silvia Bio with similar companies based on industry and business-model similarity.

Silvia Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
64x Bio
76%
InVitria
75%
JSR Life Sciences
70%

Silvia Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 15, 2026

Silvia Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 15, 2026

    $4M round led by Northern Gritstone.

Recent news

Latest coverage and updates

  • expands_facilitiesOct 16, 2026

    Silvia Bio Ltd plans to move from university facilities to dedicated laboratory premises at Sheffield’s Innovation Centre, with funding enabling the expansion.

  • receives_financingOct 15, 2026

    Silvia Bio Ltd secures $3.97M in Seed financing led by Northern Gritstone, with participation from Parkwalk, the UK Innovation & Science Seed Fund, Wren Capital, and angel investors, to reduce the cost of producing biologic drugs on Oct 15th '26 in the United Kingdom.

Silvia Bio Filings

Explore SEC and related filing metadata, where available.

Silvia Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Silvia Bio's valuation, stock price, and market status.

Is Silvia Bio a public or private company?

Silvia Bio is a private company.

What is the current stock price of Silvia Bio?

Silvia Bio is a private company, so its shares have no public market price. Caplight tracks Silvia Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Silvia Bio worth (valuation)?

Valuation information for Silvia Bio is not publicly available.

Can I buy Silvia Bio stock?

Silvia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Silvia Bio's last funding round?

Silvia Bio's most recent funding round was Seed on October 15, 2026.

Who are the main investors in Silvia Bio?

Key investors in Silvia Bio include Northern Gritstone.

Will Silvia Bio IPO soon?

No public IPO plans have been announced for Silvia Bio.

How can I track Silvia Bio secondary market activity?

Caplight tracks bids, offers, and trades in Silvia Bio's shares on secondary markets.

Firmographic Details

HeadquartersSheffield
Year Founded2025
Last FundingOct 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?